Global Carrier Screening Market 2025-2029

Carrier Screening Market 2025-2029

The carrier screening market is forecasted to grow by USD 3897.9 mn during 2024-2029, accelerating at a CAGR of 22.5% during the forecast period. The report on the carrier screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of genetic diseases and disorders, increasing prevalence of fetal chromosomal abnormalities, and rising consciousness among masses regarding benefits of early detection and diagnosis of diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's carrier screening market is segmented as below:

By Type

• Expanded
• Targeted disease

By Technology

• DNA sequencing
• Polymerase chain reaction (PCR)
• Microarrays
• Others

By Test

• Molecular screening tests
• Biochemical screening tests

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising trends of next-generation sequencing (NGS) technology in carrier screening as one of the prime reasons driving the carrier screening market growth during the next few years. Also, extensive research and development activities in field of biotechnology and bioinformatics and significant growth in medical infrastructure will lead to sizable demand in the market.

The report on the carrier screening market covers the following areas:

• Carrier Screening Market sizing
• Carrier Screening Market forecast
• Carrier Screening Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading carrier screening market vendors that include Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., DiaSorin SpA, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Fulgent Genetics Inc., Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc.. Also, the carrier screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.